Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
Completed · Phase 2
Conditions studied: Stroke
In brief
The purpose of this study is to refine and evaluate the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention. PROTECT DC is a program consisting of in-hospital education coupled with community-based "stroke navigators" and is designed to reduce the rate of vascular events or death in a population of underserved individuals with stroke.
Key facts
- Study ID
- NCT00703274
- Run by
- Georgetown University
- People needed
- 230
- Starts
- 2008-04-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2013-02-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Hospitalized due to ischemic stroke* or intercurrent ischemic stroke* event within the past 30 days OR Transient ischemic attack, confirmed by stroke neurologist.
- Atherogenic etiology(large vessel, small vessel, cryptogenic with at least one stroke risk factor, or embolic stroke due to atherogenic cardiac disease) as defined by TOAST criteria.
- Community dwelling prior to stroke
- Resides within the District of Columbia or closely nearby (preferably within 10 miles of the DC border)
- Expected to reside within the District of Columbia or closely nearby (preferably within 10 miles of DC border)
- Caregiver or interested party available, if moderately or severely disabled (not required to actually reside with participant)
- Sufficient number of collateral contacts to assure follow-up. Defined as: Preferred: at least 6 contacts; and No fewer than 3 contacts (unless approved by study PI/co-PI/co-I)
- Judged likely to return to community setting at completion of post-acute care.
You may not qualify if…
- Non-atherogenic cause of stroke
- NIHSS > 20
- Any medical condition that would limit participation in follow up assessments
- Baseline dementia per informant report (AD8) or screening assessment (Short Blessed Memory Orientation Concentration Test)
Where it is running
- Georgetown University Hospital — Washington D.C., District of Columbia, United States
- National Rehabilitation Hospital — Washington D.C., District of Columbia, United States
- Washington Hospital Center — Washington D.C., District of Columbia, United States
- Providence Hospital — Washington D.C., District of Columbia, United States
- George Washington University Hospital — Washington D.C., District of Columbia, United States
- Howard University Hospital — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.